-
US expands scope of MSD's Gardasil
pharmatimes
June 16, 2020
MSD has bagged US approval for an expanded indication for Gardasil for the prevention of oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, and 58.
-
Merck to build Gardasil 9 plant and add 425 jobs, but will cut 150 elsewhere
fiercepharma
July 28, 2019
Merck’s Gardasil is not just a moneymaker, it is a job creator. Just weeks after announcing a Virginia expansion to produce the vaccine and add 100 jobs, the drugmaker says it will build a new plant for Gardasil in North Carolina with 425 more.
-
Merck quadruples Gardasil supply in China contract but still might not meet full demand
expressbpd
November 13, 2018
Facing buoyant demand in China for its HPV vaccines on the back of its Gardasil 9 launch, Merck & Co. has promised almost quadrupled supply in the coming years in a renewed contract with a local distributor.
-
'Unprecedented' demand for Merck's Gardasil drives monster Q3
fiercepharma
November 09, 2018
Merck’s Gardasil has been propelling the pharma giant’s vaccine unit in recent quarters, and that doesn't look like it'll be changing. The company sees more growth
-
Despite high-flying Gardasil sales, Merck executives see 'significant' opportunity ahead
fiercepharma
August 01, 2018
When Merck reported second-quarter results last week, many pharma watchers tuned in to the fact that its blockbuster cancer fighter Keytruda finally passed market rival Opdivo in quarterly sales. Meanwhile, the company's big-selling HPV shot.....
-
U.K. to offer Merck's Gardasil to boys after years of protests
fiercepharma
July 25, 2018
Based on a recommendation from the Joint Committee on Vaccination and Immunisation (JCVI), the U.K. government announced on Tuesday that the vaccine will be offered to boys aged 12 and 13 in an effort to protect them against several types of cancer caused
-
With global supplies running short, stepped-up Chinese demand paralyzes Gardasil market in Hong Kong, S.A.R., China
fiercepharma
May 29, 2018
Before Merck & Co.'s Gardasil 9 won conditional approval on the mainland just last month...
-
Boosted by China launch, Merck's Gardasil turns in a big first-quarter performance
fiercepharma
May 09, 2018
Even as Merck's Gardasil sales suffer in the U.S. from the CDC's decision to implement a two-dose regimen, the HPV vaccine franchise posted strong growth in the first quarter as a China launch begins to pay off.
-
Gardasil's growth led Merck's vaccine sales of $6.5B in 2017 as Zostavax struggles
fiercepharma
February 07, 2018
Merck's vaccine business kept churning in 2017, generating sales of $6.5 billion and growing by 4.8% over the prior year.
-
HPV vaccination rates ticking upward, CDC says as it urges more uptake
fiercepharma
August 30, 2017
Sixty percent of U.S. teens aged 13 to 17 received an HPV vaccine dose last year, according to the CDC.